Literature DB >> 10900153

Prion diseases and the immune system.

P Aucouturier1, R I Carp, C Carnaud, T Wisniewski.   

Abstract

Transmissible spongiform encephalopathies are caused by unusual infectious agents that are purported to contain a single type of macromolecule, a modified host glycoprotein. The term prion has been applied to this group of agents. Surprisingly, the immune system appears to behave as a Trojan's horse rather than a protective fortification during prion infections. Because prions seem to be essentially composed of a protein, PrP(Sc), identical in sequence to a host encoded protein, PrP(C), the specific immune system displays a natural tolerance. However, lymphoid organs are strongly implicated in the preclinical stages of the disease. Certain immunodeficient animals are resistant to prions after peripheral inoculation. In normal subjects, cells of the immune system support the replication of prions and/or allow neuroinvasion. A better understanding of these aspects of prion diseases could lead to immunomanipulation strategies aimed at preventing the spread of infectious agents to the central nervous system. Copyright 2000 Academic Press.

Entities:  

Mesh:

Year:  2000        PMID: 10900153     DOI: 10.1006/clim.2000.4875

Source DB:  PubMed          Journal:  Clin Immunol        ISSN: 1521-6616            Impact factor:   3.969


  13 in total

1.  The quantification of prion gene expression in sheep using real-time RT-PCR.

Authors:  Cai-Xia Han; Hong-Xiang Liu; De-Ming Zhao
Journal:  Virus Genes       Date:  2006-12       Impact factor: 2.332

2.  Cloning and Expression of Iranian Turkmen-thoroughbred Horse Follicle Stimulating Hormone in Pichia pastoris.

Authors:  Zahra Elyasi Gorji; Amir Amiri-Yekta; Hamid Gourabi; Saeed Hassani; Nayeralsadat Fatemi; Saeed Zerehdaran; Faezeh Vakhshiteh; Mohammad Hossein Sanati
Journal:  Iran J Biotechnol       Date:  2015-06       Impact factor: 1.671

3.  Could immunomodulation be used to prevent prion diseases?

Authors:  Thomas Wisniewski; Fernando Goñi
Journal:  Expert Rev Anti Infect Ther       Date:  2012-03       Impact factor: 5.091

Review 4.  Immunomodulation for prion and prion-related diseases.

Authors:  Thomas Wisniewski; Fernando Goñi
Journal:  Expert Rev Vaccines       Date:  2010-12       Impact factor: 5.217

5.  T cells infiltrate the brain in murine and human transmissible spongiform encephalopathies.

Authors:  Hanna Lewicki; Antoinette Tishon; Dirk Homann; Honoré Mazarguil; Françoise Laval; Valerie C Asensio; Iain L Campbell; Stephen DeArmond; Bryan Coon; Chao Teng; Jean Edouard Gairin; Michael B A Oldstone
Journal:  J Virol       Date:  2003-03       Impact factor: 5.103

6.  Immunization delays the onset of prion disease in mice.

Authors:  Einar M Sigurdsson; David R Brown; Maki Daniels; Richard J Kascsak; Regina Kascsak; Richard Carp; Harry C Meeker; Blas Frangione; Thomas Wisniewski
Journal:  Am J Pathol       Date:  2002-07       Impact factor: 4.307

7.  High titers of mucosal and systemic anti-PrP antibodies abrogate oral prion infection in mucosal-vaccinated mice.

Authors:  F Goñi; F Prelli; F Schreiber; H Scholtzova; E Chung; R Kascsak; D R Brown; E M Sigurdsson; J A Chabalgoity; T Wisniewski
Journal:  Neuroscience       Date:  2008-03-06       Impact factor: 3.590

8.  Vaccination with prion peptide-displaying papillomavirus-like particles induces autoantibodies to normal prion protein that interfere with pathologic prion protein production in infected cells.

Authors:  Alessandra Handisurya; Sabine Gilch; Dorian Winter; Saeed Shafti-Keramat; Dieter Maurer; Hermann M Schätzl; Reinhard Kirnbauer
Journal:  FEBS J       Date:  2007-02-20       Impact factor: 5.542

9.  Immunization of cervidized transgenic mice with multimeric deer prion protein induces self-antibodies that antagonize chronic wasting disease infectivity in vitro.

Authors:  Dalia H Abdelaziz; Simrika Thapa; Basant Abdulrahman; Li Lu; Shikha Jain; Hermann M Schatzl
Journal:  Sci Rep       Date:  2017-09-05       Impact factor: 4.379

10.  Anti-idiotypic antibodies: a new approach in prion research.

Authors:  Anja Colja Venturini; Maja Bresjanac; Tanja Vranac; Simon Koren; Mojca Narat; Mara Popović; Vladka Curin Serbec
Journal:  BMC Immunol       Date:  2009-03-19       Impact factor: 3.615

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.